Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Published on: Wednesday 30 January 2019
About sleeping sickness The majority of sleeping sickness patients live in the Democratic Republic of Congo, where 85% of Trypanosoma brucei ... Federal Ministry of Education and Research (BMBF) ...